Florida Surgery And Weight Loss Center offers physician-guided GLP-1 and GLP-1/GIP weight-loss programs designed to help eligible patients achieve sustainable weight loss, improve appetite control, and support long-term metabolic health
, le Roux, C
Wegovy, a semaglutide formulation approved for weight loss, is included in just 1% of Marketplace plan formularies, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies
However, it is essential to note that when additional pharmacological intervention is required to control diabetes mellitus, the choice between SGLT-2 inhibitors and GLP-1 RAs should be based on the patients individual needs and the specific medications already being used
But rapid weight loss especially in the absence of strength training or adequate protein intakeoften comes at the cost of lean body mass